Rankings
▼
Calendar
BDX Q4 2023 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena
BDX
Becton, Dickinson and Company
$60B
Q4 2023 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$5.1B
+6.8% YoY
Gross Profit
$1.7B
33.4% margin
Operating Income
$349M
6.9% margin
Net Income
$108M
2.1% margin
EPS (Diluted)
$0.37
QoQ Revenue Growth
+4.3%
Cash Flow
Operating Cash Flow
$1.3B
Free Cash Flow
$1.0B
Stock-Based Comp.
$58M
Balance Sheet
Total Assets
$52.8B
Total Liabilities
$27.0B
Stockholders' Equity
$25.8B
Cash & Equivalents
$1.4B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.1B
$4.8B
+6.8%
Gross Profit
$1.7B
$2.1B
-18.1%
Operating Income
$349M
$489M
-28.6%
Net Income
$108M
$288M
-62.5%
Revenue Segments
Medical
$2.6B
50%
Life Sciences
$1.3B
26%
Interventional
$1.2B
24%
Geographic Segments
UNITED STATES
$2.9B
57%
Non-US
$2.2B
43%
← FY 2023
All Quarters
Q1 2024 →